You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

Details for New Drug Application (NDA): 062640

✉ Email this page to a colleague

« Back to Dashboard

NDA 062640 describes CEFTAZIDIME, which is a drug marketed by Acs Dobfar, Aurobindo Pharma Ltd, Wockhardt, B Braun, and Baxter Hlthcare, and is included in six NDAs. It is available from two suppliers. Additional details are available on the CEFTAZIDIME profile page.

The generic ingredient in CEFTAZIDIME is ceftazidime sodium. There are seventeen drug master file entries for this compound. Additional details are available on the ceftazidime sodium profile page.

Summary for 062640

Tradename:	CEFTAZIDIME
Applicant:	Acs Dobfar
Ingredient:	ceftazidime
Patents:	0

Pharmacology for NDA: 062640

Medical Subject Heading (MeSH) Categories for 062640

Anti-Bacterial Agents

Suppliers and Packaging for NDA: 062640

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CEFTAZIDIME	ceftazidime	INJECTABLE;INJECTION	062640	ANDA	Sagent Pharmaceuticals	25021-127	25021-127-20	25 VIAL in 1 CARTON (25021-127-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
CEFTAZIDIME	ceftazidime	INJECTABLE;INJECTION	062640	ANDA	Sagent Pharmaceuticals	25021-128	25021-128-50	10 VIAL in 1 CARTON (25021-128-50) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	INJECTABLE;INJECTION			Strength	500MG/VIAL
Approval Date:	Nov 20, 1985	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	1GM/VIAL
Approval Date:	Nov 20, 1985	TE:	AP	RLD:	No

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	2GM/VIAL
Approval Date:	Nov 20, 1985	TE:	AP	RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.